Cure My Disease

Don't miss your cure!

 Log in / Sign up

New weapon against tough cancers: experimental drug enters human testing

NCT ID NCT04485013

Recruiting now Disease control Sponsor: Tizona Therapeutics, Inc Source: ClinicalTrials.gov ↗

Summary

This early-stage trial is testing a new drug called TTX-080, both alone and combined with other cancer therapies, for people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses and see if the drug shows any signs of fighting the cancer. The study is currently enrolling adults with advanced colorectal cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AdventHealth Research Institute

    COMPLETED

    Orlando, Florida, 32804, United States

  • American Oncology Partners, P.A. - The Center for Cancer & Blood Disorders

    RECRUITING

    Bethesda, Maryland, 20817, United States

    Contact Phone: •••-•••-••••

  • Arizona Oncology Associates

    COMPLETED

    Tucson, Arizona, 85711, United States

  • Christiana Care Helen F. Graham Cancer Center

    COMPLETED

    Newark, Delaware, 19713, United States

  • Dana-Farber Cancer Institute

    COMPLETED

    Boston, Massachusetts, 02215, United States

  • Florida Cancer Specialists

    RECRUITING

    Daytona Beach, Florida, 32117, United States

    Contact Phone: •••-•••-••••

  • Florida Cancer Specialists

    COMPLETED

    Fleming Island, Florida, 32003, United States

  • Hoag Memorial Hospital

    COMPLETED

    Newport Beach, California, 92663, United States

  • Icahn School of Medicine at Mount Sinai

    COMPLETED

    New York, New York, 10029, United States

  • Illinois Cancer Specialists

    COMPLETED

    Arlington Heights, Illinois, 60005, United States

  • Indiana University

    COMPLETED

    Indianapolis, Indiana, 46202, United States

  • John Hopkins Kimmer Cancer Center

    COMPLETED

    Washington D.C., District of Columbia, 20016, United States

  • Maryland Oncology Hematology

    RECRUITING

    Silver Spring, Maryland, 20904, United States

    Contact Phone: •••-•••-••••

  • Medical University of South Carolina

    COMPLETED

    Charleston, South Carolina, 29425, United States

  • NEXT Oncology

    COMPLETED

    San Antonio, Texas, 78229, United States

  • NEXT Oncology Virginia

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-••••

  • Nebraska Cancer Center Oncology Hematology West P.C.

    RECRUITING

    Omaha, Nebraska, 68130, United States

    Contact Phone: •••-•••-••••

  • Northwest Cancer Specialists

    COMPLETED

    Vancouver, Washington, 98684, United States

  • Northwest Medical Specialties

    COMPLETED

    Tacoma, Washington, 98405, United States

  • Norton Cancer Institute

    COMPLETED

    Louisville, Kentucky, 40241, United States

  • Ocala Oncology Center

    RECRUITING

    Ocala, Florida, 34474, United States

    Contact Phone: •••-•••-••••

  • Regions Hospital Cancer Care Center

    RECRUITING

    Saint Paul, Minnesota, 55101, United States

    Contact Phone: •••-•••-••••

  • Rocky Mountain Cancer Centers

    RECRUITING

    Denver, Colorado, 80218, United States

    Contact Phone: •••-•••-••••

  • Rutgers Cancer Institute of New Jersey

    RECRUITING

    New Brunswick, New Jersey, 08903, United States

    Contact Phone: •••-•••-••••

  • START Dallas

    RECRUITING

    Fort Worth, Texas, 76104, United States

    Contact Phone: •••-•••-••••

  • START Midwest

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

    Contact Phone: •••-•••-••••

  • Sarah Cannon Research Institute

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact Phone: •••-•••-••••

  • Stony Brook University

    COMPLETED

    Stony Brook, New York, 11794, United States

  • Texas Oncology - Dallas

    RECRUITING

    Dallas, Texas, 75246, United States

    Contact Phone: •••-•••-••••

  • Texas Oncology - Paris

    RECRUITING

    Paris, Texas, 75460, United States

    Contact Phone: •••-•••-••••

  • The University of Texas MD Anderson Cancer Center

    COMPLETED

    Houston, Texas, 77030, United States

  • The University of Toledo

    COMPLETED

    Toledo, Ohio, 43606, United States

  • University of Cincinnati

    RECRUITING

    Cincinnati, Ohio, 45267, United States

    Contact Phone: •••-•••-••••

  • University of Illinois

    COMPLETED

    Chicago, Illinois, 60612, United States

  • University of Oklahoma

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

    Contact Phone: •••-•••-••••

  • University of Pittsburgh Medical Center

    COMPLETED

    Pittsburgh, Pennsylvania, 15232, United States

  • University of Southern California

    COMPLETED

    Los Angeles, California, 90033, United States

  • Vanderbilt - Ingram Cancer Center

    COMPLETED

    Nashville, Tennessee, 37232, United States

  • Washington University in St Louis

    COMPLETED

    St Louis, Missouri, 63110, United States

  • Yale Cancer Center

    COMPLETED

    New Haven, Connecticut, 06511, United States

  • Zangmeister Cancer Center

    COMPLETED

    Columbus, Ohio, 43219, United States

Conditions

Explore the condition pages connected to this study.

CANCER